We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

106 hedge funds and large institutions have $400M invested in GenMark Diagnostics, Inc in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $355M → $400M (+$45.8M)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 105 → 106 (+1)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

Holders
106
Holders Change
+1
Holders Change %
+0.95%
% of All Funds
2.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
34
Reduced
34
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$1.93M
2
BlackRock
BlackRock
New York
+$1.84M
3
State Street
State Street
Massachusetts
+$1.4M
4
BG
Bellevue Group
Switzerland
+$1.12M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$842K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$7.28M
2
CCM
Cadian Capital Management
New York
-$4.76M
3
PI
Putnam Investments
Massachusetts
-$1.52M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.47M
5
Morgan Stanley
Morgan Stanley
New York
-$1.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJA
76
Raymond James & Associates
Florida
$136K – – –
UBS Group
77
UBS Group
Switzerland
$128K +$42.4K +5,773 +50%
JG
78
Jefferies Group
New York
$107K -$97.8K -13,333 -48%
Citigroup
79
Citigroup
New York
$105K +$50.3K +6,850 +92%
Commonwealth Equity Services
80
Commonwealth Equity Services
Massachusetts
$102K -$29.3K -4,000 -22%
FRM
81
Fox Run Management
Connecticut
$94K -$99.7K -13,588 -52%
Principal Financial Group
82
Principal Financial Group
Iowa
$79K +$78.8K +10,735 New
JT
83
Jump Trading
Illinois
$78K +$77.9K +10,620 New
GF
84
Gabelli Funds
New York
$76K – – –
TRCT
85
Tower Research Capital (TRC)
New York
$59K -$8.42K -1,147 -12%
Legal & General Group
86
Legal & General Group
United Kingdom
$56K – – –
Canada Life
87
Canada Life
Manitoba, Canada
$54K – – –
Victory Capital Management
88
Victory Capital Management
Texas
$54K +$7.15K +974 +15%
TWA
89
TCI Wealth Advisors
Arizona
$50K – – –
IF
90
Ironwood Financial
Arizona
$29K -$3.74K -510 -11%
AIP
91
Ameritas Investment Partners
Nebraska
$27K – – –
Bank of Montreal
92
Bank of Montreal
Ontario, Canada
$26K -$81 -11 -0.3%
Zurich Cantonal Bank
93
Zurich Cantonal Bank
Switzerland
$26K +$17.4K +2,367 +192%
LTFS
94
Ladenburg Thalmann Financial Services
Florida
$15K – – –
First Manhattan
95
First Manhattan
New York
$14K – – –
PCM
96
Prelude Capital Management
New York
$14K +$13.7K +1,865 New
BNP Paribas Financial Markets
97
BNP Paribas Financial Markets
France
$13.7K -$1.33K -182 -9%
RE
98
RBC Europe
United Kingdom
$13.2K – – –
QCG
99
Quadrant Capital Group
Ohio
$11K – – –
Royal Bank of Canada
100
Royal Bank of Canada
Ontario, Canada
$8K +$7.19K +980 +1,607%
1 2 3
4
5

GNMK Hedge Fund Activity: Q3 2018 in Review

106 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2018, worth a combined $400M — up 13% from $355M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GNMK positions and 10 closed out — a net gain of 1 holder — while 34 added to existing stakes and 34 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $1.93M. The largest seller was Alyeska Investment Group, cutting an estimated $7.28M.

  • 106 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2018, up from 105 in Q2 2018.
  • Funds reported $400M of GenMark Diagnostics, Inc stock for Q3 2018, up 13% quarter-over-quarter.
  • 11 funds opened new GenMark Diagnostics, Inc positions in Q3 2018 and 10 closed out, a net change of +1 holder.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2018 was Deutsche Bank, an estimated $1.93M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2018 was Alyeska Investment Group, an estimated $7.28M sold.

Based on aggregated 13F filings for Q3 2018.